A Study Using fMRI Imaging to Evaluate the Effect of NKTR-181 on Brain Activity in Healthy, Non-physically Dependent Recreational Opioid Users.

NCT03802227 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Moderate to Severe Chronic Pain

Interventions

DRUG: NKTR-181
DRUG: Oxycodone IR

Sponsor

Nektar Therapeutics